Clinical Trials for Fludarabine (Fludara)

4 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TherapeuticVICCNCBMT12108
05/08/2013
A Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched and HLA-Matched Bone Marrow for Patients with Sickle Cell Disease and Other Hemoglobinopathies
TherapeuticVICCTHN1163
05/15/2012
Phase 1, Open-label Study Evaluating the Safety of Escalating Doses of Ad/PNP-F-araAMP (Ad/PNP Administered Intratumorally with Co-administration of Fludarabine Phosphate Intravenously) in Subjects with Advanced Solid Tumors
TherapeuticVICCNCPED1099
06/04/2010
Nonmyeloablative Hematopoietic Cell Transplantation for Patients with Fanconi Anemia Using Alternative Marrow Donors: A Phase I/II Dose-Finding Study
TherapeuticVICCNCPED10101
12/28/2006
Hematopoietic Cell Transplantation for Treatment of Patients with Primary Immunodeficiencies and Other Nonmalignant Inherited Disorders Using Low-Dose TBI and Fludarabine with or without Campath

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.